JenniferScaliciMD

PubMed

• 1 citations
  A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...
  Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
• Perivascular epithelioid cell tumor (PEComa) of the uterus: Challenges of pregnancy in determining prognosis and optimal treatment.
  Annelise M Wilhite, Valeria Dal Zotto, Paige Pettus, Julie Jeansonne, Jennifer Scalici> ;Gynecologic Oncology Reports. 2022 Apr 1
• 31 citations
  Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
  Linda R. Duska, Jennifer Scalici, Sarah M. Temkin, Julie K. Schwarz, Erin K. Crane, Katherine M. Moxley, Chad A. Hamilton, Stephanie L. Wethington, Gina R. Petroni, Ni...> ;Cancer. 2020 Nov 15
• 18 citations
  Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
  Eli K Awad, Rajesh Paladugu, N.L. Jones, Jennifer Young Pierce, Jennifer Scalici, Chad A. Hamilton, Kathleen M. Darcy, G. Larry Maxwell, Rodney P. Rocconi> ;Gynecologic Oncology. 2020 Mar 13
• 2 citations
  HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
  M. Edler, A. Fernandez, K. Anderson, Jennifer Young Pierce, Jennifer Scalici, Casey L. Daniel> ;Vaccine. 2019 Jan 21
• Para-aortic lymph node dissection for women with endometrial adenocarcinoma and intermediate- to high-risk tumors: does it improve survival?
  Courtney-Brooks M, Scalici JM, Tellawi AR, Cantrell LA, Duska LR> ;International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
• 31 citations
  Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation
  Kaushlendra Tripathi, Usama Khamis Hussein, Roja Anupalli, Reagan M. Barnett, Jennifer Scalici, Rodney P. Rocconi, Laurie B. Owen, Gary A. Piazza, Komaraiah Palle> ;Oncotarget. 2015 Feb 20
• 46 citations
  RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
  Ranganatha R. Somasagara, Sebastian M. Spencer, Kaushlendra Tripathi, David W. Clark, Chinnadurai Mani, Jennifer Scalici, Hend Kothayer, Andrew D. Westwell, Rodney P. ...> ;Oncogene. 2017 Aug 14
• MicroRNAs in gynecological cancers: Small molecules with big implications.
  Srivastava SK, Ahmad A, Zubair H, Miree O, Singh S, Rocconi RP, Scalici J, Singh AP> ;Cancer letters. 2017-05-24
• 507 citations
  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
  Emma C. Rossi, Lynn D. Kowalski, Jennifer Scalici, Leigh A. Cantrell, Kevin Schuler, R.K. Hanna, Michael Method, Melissa Ade, Anastasia Ivanova, John F. Boggess> ;The Lancet. Oncology. 2017 Mar 1
• Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
  Scalici JM, Arapovic S, Saks EJ, Atkins KA, Petroni G, Duska LR, Slack-Davis JK> ;Cancer. 2016-11-07
• 25 citations
  Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
  J.G. Ross, Katelyn V. Braswell, Luciana Madeira da Silva, Frances Currin Mujica, Sam Stutsman, Michael A. Finan, William Nicolson, Mary Danner Harmon, Megan Missanelli...> ;Gynecologic Oncology. 2016 Jun 1
• 15 citations
  Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer.
  Ranganatha R. Somasagara, Kaushlendra Tripathi, Sebastian M. Spencer, David W. Clark, Reagan M. Barnett, Jennifer Scalici, Rodney P. Rocconi, Gary A. Piazza, Komaraiah...> ;Biochemical and Biophysical Research Communications. 2016 Jan 15
• The trend towards minimally invasive surgery (MIS) for endometrial cancer: an ACS-NSQIP evaluation of surgical outcomes.
  Scalici J, Laughlin BB, Finan MA, Wang B, Rocconi RP> ;Gynecologic oncology. 2014-11-20
• ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
  Meng E, Mitra A, Tripathi K, Finan MA, Scalici J, McClellan S, Madeira da Silva L, Reed E, Shevde LA, Palle K, Rocconi RP> ;PloS one. 2014-09-12
• Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
  Scalici JM, Harrer C, Allen A, Jazaeri A, Atkins KA, McLachlan KR, Slack-Davis JK> ;Gynecologic oncology. 2013-12-28
• Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer.
  Scalici JM, Thomas S, Harrer C, Raines TA, Curran J, Atkins KA, Conaway MR, Duska L, Kelly KA, Slack-Davis JK> ;Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2013-09-12
• Vulvar necrotizing soft tissue infection: A review of a multi-disciplinary surgical emergency and management in the modern era.
  Courtney-Brooks M, Scalici J, Henretta MS, Modesitt SC, Jazaeri AA, Cantrell LA, Duska LR> ;Gynecologic oncology case reports. 2013-02-11
• 96 citations
  Frailty: An outcome predictor for elderly gynecologic oncology patients ☆
  Madeleine Courtney-Brooks, Jennifer M. Scalici, Linda R. Duska, Amir A. Jazaeri, Susan C. Modesitt, Leigh A. Cantrell> ;Gynecologic Oncology. 2012 Jul 1
• The revolving door: hospital readmissions of gynecologic oncology patients.
  Henretta MS, Scalici JM, Engelhard CL, Duska LR> ;Gynecologic oncology. 2011-06-12
• Join now to see all